Former Alnylam CEO appointed new chair of Hemab

Biotech company Hemab starts the year by welcoming two new faces to the board, including former Alnylam CEO John Maraganore as chair. Hemab also appoints a new member to leadership.
Benny Sørensen, CEO of Hemab, is "delighted" to begin the new year by welcoming three new faces to Hemab | Photo: Hemab / PR
Benny Sørensen, CEO of Hemab, is "delighted" to begin the new year by welcoming three new faces to Hemab | Photo: Hemab / PR
by CHRISTOPHER DUE KARLSSON, translated by daniel pedersen

On Wednesday, biotech company Hemab presented a string of new people who will soon join either Hemab's board of directors or the company's management, as reported in a in a press release.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading